399 related articles for article (PubMed ID: 34447235)
1. Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study.
Pereira ENGDS; Paula DP; de Araujo BP; da Fonseca MJM; Diniz MFHS; Daliry A; Griep RH
World J Gastroenterol; 2021 Aug; 27(29):4913-4928. PubMed ID: 34447235
[TBL] [Abstract][Full Text] [Related]
2. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of a noninvasive hepatic ultrasound score for non-alcoholic fatty liver disease (NAFLD) in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
Goulart AC; Oliveira IR; Alencar AP; Santos MS; Santos IS; Martines BM; Meireles DP; Martines JA; Misciagna G; Benseñor IM; Lotufo PA
Sao Paulo Med J; 2015; 133(2):115-24. PubMed ID: 26018881
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
Palma-Duran SA; Kontogianni MD; Vlassopoulos A; Zhao S; Margariti A; Georgoulis M; Papatheodoridis G; Combet E
Metabolism; 2018 Jun; 83():120-127. PubMed ID: 29409822
[TBL] [Abstract][Full Text] [Related]
5. Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.
Liu PJ; Ma F; Lou HP; Zhu YN; Chen Y
Climacteric; 2014 Dec; 17(6):692-9. PubMed ID: 24884478
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Liver Steatosis Applying a New Score in Subjects from the Brazilian Longitudinal Study of Adult Health.
Perazzo H; Benseñor I; Mill JG; Pacheco AG; da Fonseca MJM; Griep RH; Lotufo P; Chor D
J Clin Gastroenterol; 2020 Jan; 54(1):e1-e10. PubMed ID: 29505553
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels of fetuin-A are associated with moderate-severe hepatic steatosis in young adults.
Filardi T; Panimolle F; Tiberti C; Crescioli C; Lenzi A; Pallotta N; Morano S
J Endocrinol Invest; 2021 Jan; 44(1):105-110. PubMed ID: 32350824
[TBL] [Abstract][Full Text] [Related]
8. Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents.
Chin J; Mori TA; Adams LA; Beilin LJ; Huang RC; Olynyk JK; Ayonrinde OT
JHEP Rep; 2020 Dec; 2(6):100150. PubMed ID: 32984791
[TBL] [Abstract][Full Text] [Related]
9. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
[TBL] [Abstract][Full Text] [Related]
10. Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.
Li XD; Qiu BH; Su FC; Sun SX
Clin Exp Hypertens; 2016; 38(7):639-643. PubMed ID: 27680771
[TBL] [Abstract][Full Text] [Related]
11. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
[TBL] [Abstract][Full Text] [Related]
12. What is the appropriate strategy for diagnosing NAFLD using ultrasonography in obese children?
Lee JH; Jeong SJ
World J Pediatr; 2017 Jun; 13(3):248-254. PubMed ID: 28101773
[TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: The ELSA-Brasil.
Harada PH; Bensenõr IJM; Drager LF; Goulart AC; Mill JG; Lotufo PA
Atherosclerosis; 2019 May; 284():59-65. PubMed ID: 30875494
[TBL] [Abstract][Full Text] [Related]
14. Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults.
Zheng X; Gong L; Luo R; Chen H; Peng B; Ren W; Wang Y
Lipids Health Dis; 2017 Oct; 16(1):202. PubMed ID: 29037239
[TBL] [Abstract][Full Text] [Related]
15. Assessment of hepatic steatosis algorithms in non-alcoholic fatty liver disease.
Eremić-Kojić N; Đerić M; Govorčin ML; Balać D; Kresoja M; Kojić-Damjanov S
Hippokratia; 2018; 22(1):10-16. PubMed ID: 31213752
[TBL] [Abstract][Full Text] [Related]
16. Follicle-stimulating hormone is associated with non-alcoholic fatty liver disease in Chinese women over 55 years old.
Wang N; Li Q; Han B; Chen Y; Zhu C; Chen Y; Xia F; Lu M; Meng Y; Guo Y; Ye L; Sui C; Kuang L; Lin D; Lu Y
J Gastroenterol Hepatol; 2016 Jun; 31(6):1196-202. PubMed ID: 26678239
[TBL] [Abstract][Full Text] [Related]
17. Association of grade of non-alcoholic fatty liver disease and glycated albumin to glycated hemoglobin ratio in patients with type 2 diabetes mellitus.
Jung CH; Lee B; Choi DH; Jung SH; Kim BY; Kim CH; Kang SK; Mok JO
Diabetes Res Clin Pract; 2017 Mar; 125():53-61. PubMed ID: 28167326
[TBL] [Abstract][Full Text] [Related]
18. Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD).
Fernández Rodríguez CM; Aller R; Gutiérrez García ML; Ampuero J; Gómez-Camarero J; Martín-Mateos RMª; Burgos-Santamaría D; Rosales JM; Aspichueta P; Buque X; Latorre M; Andrade RJ; Hernández-Guerra M; Romero-Gómez M
Rev Esp Enferm Dig; 2019 Apr; 111(4):264-269. PubMed ID: 30810330
[TBL] [Abstract][Full Text] [Related]
19. Serum fetuin-B level is an independent marker for nonalcoholic fatty liver disease in patients with type 2 diabetes.
El-Ashmawy HM; Ahmed AM
Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):859-864. PubMed ID: 30601337
[TBL] [Abstract][Full Text] [Related]
20. Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity.
Zhu WH; Fang LZ; Lu CR; Dai HL; Chen JH; Qiao QH; Chen LY
World J Gastroenterol; 2015 Sep; 21(35):10192-9. PubMed ID: 26401084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
